Skip to content

Definitive Healthcare Corp. DH Accounts Receivable, Credit Loss Expense (Reversal)

Accounts Receivable, Credit Loss Expense (Reversal) at other companies

Teladoc Health logo
Teladoc HealthTDOC
SS&C Technologies logo
SS&C TechnologiesSSNC

Other financials

Income statement

See full
Revenue$55.9M-5.5%
Gross profit$46.6M-5.0%
Operating income-$201.3M-8.9%
Net income-$138.6M-29.3%
EPS (diluted)-$1.32-38.9%

Balance sheet

See full
Cash & equivalents$157.6M+48.6%
Total debt$169.8M-6.0%
Total assets$514.7M-36.3%

Cash flow

See full
Operating cash flow$11.6M-55.6%
CapEx$3.2M-58.4%
Free cash flow$8.4M-54.5%

Valuation

See full
Market cap$87.68M-79.8%
Enterprise value$99.87M-81.2%
P/S0.4×-1.4×

Profitability

See full
Gross margin84.4%+1.0pp
Operating margin-101.1%-42.1pp
Net margin-71.5%-28.2pp
FCF margin12.1%-8.4pp

Returns & leverage

See full
Current ratio1.8×0.0×

Where this comes from

Reported directly by Definitive Healthcare Corp. in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: Definitive Healthcare Corp.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Definitive Healthcare Corp.'s accounts receivable, credit loss expense (reversal).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Definitive Healthcare Corp.'s accounts receivable, credit loss expense (reversal)?
Definitive Healthcare Corp. (DH) reported accounts receivable, credit loss expense (reversal) of -$208K in Q1 2026.
How has Definitive Healthcare Corp.'s accounts receivable, credit loss expense (reversal) changed year-over-year?
Definitive Healthcare Corp.'s accounts receivable, credit loss expense (reversal) decreased by 46.5% year-over-year, from -$142K to -$208K.
What is the long-term trend for Definitive Healthcare Corp.'s accounts receivable, credit loss expense (reversal)?
Over 2 years (2022 to 2024), Definitive Healthcare Corp.'s accounts receivable, credit loss expense (reversal) has grown at a -15.5% compound annual growth rate (CAGR), from $1.33M to $947K.